Regeneus in TechInvest

In July, Regeneus CEO Karolis Rosickas contributed an article to TechInvest Magazine – a quarterly publication for the tech and innovation sector featured in The Australian Financial Review.

In an article titled ‘For a life free of pain’, Karolis Rosickas explains how Regeneus is potentially one clinical trial away from generating revenue from Progenza™ in Japan. Read the article here.